Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bergmann

Showing results (161-170 of 206) with videos related to

Pageof 21
Sort By:
Basic & Clinical Pharmacology & Toxicology|October 2, 2021
No significant influence of OCT1 genotypes on the pharmacokinetics of morphine in adult surgical patientsIda Kuhlmann, Rasmus Hjelmar Petersen, Morten Overgaard, et al.
Clinical Pharmacology and Therapeutics|February 23, 2017
Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic StudyK Agergaard, M Mau-Sørensen, T B Stage, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2019
A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24Mansoor Raza Mirza, Troels K Bergmann, Morten Mau-Sørensen, et al.
British Journal of Clinical Pharmacology|October 11, 2024
Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patientsKatrine Agergaard, Helle C Thiesson, Jan Carstens, et al.
The Pharmacogenomics Journal|April 7, 2010
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancerT K Bergmann, C Brasch-Andersen, H Gréen, et al.
Annals of Hematology|January 18, 2023
Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemiaMartin Stanulla, Denis M Schewe, Beat Bornhauser, et al.
Blood|July 18, 2019
Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemiaFotini Vogiatzi, Dorothee Winterberg, Lennart Lenk, et al.
Zeitschrift Fur Die Gesamte Hygiene Und Ihre Grenzgebiete|September 1, 1971
[Aircraft noise as problem of hygiene in living and working conditions--medical observations on subjects residing near the central airport Berlin-Schönefeld using interviews]D Herrmann, K Horn, H Theodor, et al.
Hemasphere|July 20, 2023
Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood <i>ETV6::RUNX1+</i> and High Hyperdiploid Acute Lymphoblastic LeukemiaDanielle Brandes, Layal Yasin, Karin Nebral, et al.
Transplantation|October 26, 2012
NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantationKatherine A Barraclough, Nicole M Isbel, Katie J Lee, et al.
Pageof 21

Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
Basic & Clinical Pharmacology & Toxicology|October 2, 2021
No significant influence of OCT1 genotypes on the pharmacokinetics of morphine in adult surgical patientsIda Kuhlmann, Rasmus Hjelmar Petersen, Morten Overgaard, et al.
Clinical Pharmacology and Therapeutics|February 23, 2017
Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic StudyK Agergaard, M Mau-Sørensen, T B Stage, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2019
A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24Mansoor Raza Mirza, Troels K Bergmann, Morten Mau-Sørensen, et al.
British Journal of Clinical Pharmacology|October 11, 2024
Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patientsKatrine Agergaard, Helle C Thiesson, Jan Carstens, et al.
The Pharmacogenomics Journal|April 7, 2010
Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancerT K Bergmann, C Brasch-Andersen, H Gréen, et al.
Annals of Hematology|January 18, 2023
Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemiaMartin Stanulla, Denis M Schewe, Beat Bornhauser, et al.
Blood|July 18, 2019
Daratumumab eradicates minimal residual disease in a preclinical model of pediatric T-cell acute lymphoblastic leukemiaFotini Vogiatzi, Dorothee Winterberg, Lennart Lenk, et al.
Zeitschrift Fur Die Gesamte Hygiene Und Ihre Grenzgebiete|September 1, 1971
[Aircraft noise as problem of hygiene in living and working conditions--medical observations on subjects residing near the central airport Berlin-Schönefeld using interviews]D Herrmann, K Horn, H Theodor, et al.
Hemasphere|July 20, 2023
Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood <i>ETV6::RUNX1+</i> and High Hyperdiploid Acute Lymphoblastic LeukemiaDanielle Brandes, Layal Yasin, Karin Nebral, et al.
Transplantation|October 26, 2012
NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantationKatherine A Barraclough, Nicole M Isbel, Katie J Lee, et al.
Pageof 21